Evidence map›Paper›PMID 23816600›Full record

ReviewRespiratory physiology & neurobiology2013

Breathing challenges in Rett syndrome: lessons learned from humans and animal models.

Jan-Marino Ramirez, Christopher Scott Ward, Jeffrey Lorenz Neul

Open access · greenAbstract readReview
In one paragraph

Review in Respiratory physiology & neurobiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Mecp2 deficiency induces dysphagia in a preclinical model of Rett syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Leptin antagonism improves Rett syndrome phenotype in symptomatic Mecp2-deficient mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Endogenous opioids and the development of the mammalian respiratory control network.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Epigenetics in rare neurological diseases.Frontiers in cell and developmental biology · 2024
    Review
  18. Review
  19. Inhibitory Synaptic Influences on Developmental Motor Disorders.International journal of molecular sciences · 2023
    Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jan-Marino RamirezCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA; Department of Neurological Surgery, University of Washington, Seattle, WA 98101, USA. Electronic address: nino1@uw.edu.
Christopher Scott Ward
Jeffrey Lorenz Neul
Texas Children's Hospital · USNeurological Surgery · US

Funding

Integrative Consequences of HypoxiaP01HL090554 · NHLBI · UNIVERSITY OF CHICAGO · PI PRABHAKAR, NANDURI R · 2008 to 2017
$21.4M
Mechanisms underlying neuromodulation-induced breathing instabilityR01HL107084 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI RAMIREZ, JAN M. · 2011 to 2014
$2.6M
Characterizing autonomic dysfunction in Rett syndrome and other MECP2 disordersR01HD062553 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NEUL, JEFFREY L · 2010 to 2014
$1.7M
Analysis of MeCP2 function in neural crest derivativesF31NS066601 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI WARD, CHRISTOPHER S · 2009 to 2011
$105k
NHLBI NIH HHS 01HL090554NHLBI NIH HHS P01 HL090554NHLBI NIH HHS R01 HL107084NHLBI NIH HHS R01HL107084NICHD NIH HHS R01 HD062553NICHD NIH HHS R01HD062553NINDS NIH HHS F31 NS066601NINDS NIH HHS F31NS066601
6 · The paper itself

Abstract

Breathing disturbances are a major challenge in Rett Syndrome (RTT). These disturbances are more pronounced during wakefulness; but irregular breathing occurs also during sleep. During the day patients can exhibit alternating bouts of hypoventilation and irregular hyperventilation. But there is significant individual variability in severity, onset, duration and type of breathing disturbances. Research in mouse models of RTT suggests that different areas in the ventrolateral medulla and pons give rise to different aspects of this breathing disorder. Pre-clinical experiments in mouse models that target different neuromodulatory and neurotransmitter receptors and MeCP2 function within glia cells can partly reverse breathing abnormalities. The success in animal models raises optimism that one day it will be possible to control or potentially cure the devastating symptoms also in human patients with RTT.

Indexed as

Disease Models, AnimalAnimalsHumansMiceNerve NetRespiration DisordersRespiratory MechanicsRett SyndromedysautonomiaMecp2Pre-Boetzinger Complex

Identifiers

PMID23816600
PMCPMC3812329
OpenAlexW2032817788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.